Cumberland Pharmaceuticals Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €32.51M -4.3% -€5.56M +3.2% -17.1% -0.012 pp -€371.25K -106.6% -1.1% -0.18 pp
    €33.95M -5.9% -€5.39M +11.1% -15.9% -0.024 pp €5.62M -37.8% 16.6% -0.085 pp
    €36.06M +16.7% -€4.85M +0.9% -13.4% +0.021 pp €9.04M +57.2% 25.1% +0.064 pp
    €30.89M -3.9% -€4.80M -15.5% -15.6% +0.021 pp €5.75M -11.1% 18.6% -0.015 pp
    €32.14M +8.9% -€5.69M -28.1% -17.7% +0.091 pp €6.46M +84.7% 20.1% +0.083 pp
    €29.52M -15.6% -€7.91M +32.3% -26.8% -0.097 pp €3.50M -44.8% 11.9% -0.063 pp
    €34.97M -1.0% -€5.98M -12.7% -17.1% +0.023 pp €6.34M +693.2% 18.1% +0.16 pp
    €35.33M +24.6% -€6.85M +744.6% -19.4% -0.17 pp €799.52K -65.5% 2.3% -0.059 pp
    €28.35M -1.5% -€810.96K -229.2% -2.9% -0.050 pp €2.32M -68.5% 8.2% -0.17 pp
    €28.77M -9.2% €627.82K -69.8% 2.2% -0.044 pp €7.36M -13.9% 25.6% -0.014 pp
    €31.68M +15.2% €2.08M -215.2% 6.6% +0.13 pp €8.55M +19.9% 27.0% +0.011 pp
    €27.49M -34.4% -€1.81M -136.0% -6.6% -0.19 pp €7.13M -14.1% 25.9% +0.061 pp
    €41.94M -4.5% €5.02M +3.3% 12.0% +0.0090 pp €8.30M +5.6% 19.8% +0.019 pp
    €43.90M +11.5% €4.86M +130.3% 11.1% +0.057 pp €7.86M +721.3% 17.9% +0.15 pp
    €39.38M +5.4% €2.11M -20.5% 5.4% -0.017 pp €957.42K -0.2% 2.4% -0.0014 pp
    €37.37M +24.1% €2.65M -35.1% 7.1% -0.065 pp €959.15K -82.9% 2.6% -0.16 pp
    €30.11M +25.0% €4.09M +17.8% 13.6% -0.0082 pp €5.61M -25.7% 18.6% -0.13 pp
    €24.09M +57.5% €3.47M -8.2% 14.4% -0.10 pp €7.55M +0.9% 31.3% -0.18 pp
    €15.29M +66.7% €3.78M +125.4% 24.7% +0.064 pp €7.48M +218.7% 48.9% +0.23 pp
    €9.18M €1.68M 18.3% €2.35M 25.6%

    Notifications